Burden of Illness Among People with Migraine and ≥ 4 Monthly Headache Days While Using Acute and/or Preventive Prescription Medications for Migraine.

Journal of Managed Care & Specialty Pharmacy
Dawn C BuseRichard B Lipton

Abstract

Migraine is a chronic disease that reduces health-related quality of life. Little is known about the burden of migraine in individuals who are potential candidates for preventive treatment with ≥ 4 monthly headache days currently using migraine medications. To characterize the burden of migraine among patients reporting ≥ 4 monthly headache days while taking acute and/or preventive migraine medications. In this retrospective, cross-sectional study, data from the 2016 U.S. National Health and Wellness Survey (N = 97,503) compared the burden of migraine among individuals self-reporting a diagnosis of migraine by a health care professional and ≥ 4 monthly headache days while using acute and/or preventive prescription migraine medications to matched nonmigraine controls. Propensity score matching across different variables (e.g., age, gender, and body mass index) was used to identify matched controls from respondents who did not self-report a diagnosis of migraine. Migraine-associated burden was measured by impairment in work productivity and daily activities (Work Productivity and Activity Impairment questionnaire), all-cause health care resource utilization (HRU), and all-cause direct and indirect costs. This analysis included 19...Continue Reading

References

Feb 27, 2003·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J-A ZwartL J Stovner
Feb 12, 2004·PharmacoEconomics·Jennifer H LoflandKevin D Frick
Jun 10, 2004·Headache·Jacqueline Pesa, Maureen J Lage
Apr 19, 2005·Headache·Richard B Lipton, Marcelo E Bigal
Apr 12, 2007·Journal of Occupational and Environmental Medicine·Kevin HawkinsMarcia F T Rupnow
Dec 12, 2007·Headache·Kevin HawkinsMarcia Rupnow
Apr 17, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Feng XieShu-Chuen Li
Aug 2, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Elisabeth HazardRichard B Lipton
Mar 18, 2009·Neurologic Clinics·Marcelo E Bigal, Richard B Lipton
Dec 6, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M LindeC Andrée
Apr 25, 2012·Neurology·S D SilbersteinUNKNOWN Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society
Sep 26, 2012·The Journal of Headache and Pain·Sait AshinaDawn C Buse
Nov 8, 2012·Journal of Neurology·Dawn C BuseRichard B Lipton
Feb 16, 2017·Annals of Neurology·Clifton L GoochAmy R Borenstein
Oct 31, 2017·Journal of Managed Care & Specialty Pharmacy·Machaon BonafedePooja Desai
Jun 8, 2018·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Mia T MinenElizabeth Seng
Jul 26, 2018·Journal of Managed Care & Specialty Pharmacy·Janet H FordSheena K Aurora
Dec 28, 2018·Headache·Dawn C BuseRichard B Lipton
Jan 22, 2019·Cephalalgia : an International Journal of Headache·David W Dodick
Sep 30, 2019·Neurologic Clinics·Andrea Pérez-MuñozFrank Andrasik

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.